Kat Lay

@katlay.bsky.social

Journalist - global health correspondent at The Guardian (kat.lay@theguardian.com)

The #Ebola Bundibugyo outbreak in NE DRC was likely underway for months before it was formally detected in mid-May. That's often the way with Ebola outbreaks, but the scale of the missed cases seems ... extraordinary. Terrific reporting by @kakape.bsky.social. www.science.org/content/arti...

EXCLUSIVE: Congo’s Ebola epidemic started at least 4 months before it was detected

A remote mining town gripped by fear saw hundreds of suspected cases before the government declared an outbreak, report says

science.org

Elon Musk’s demolition of USAID, and the resulting suffering and death, “is going to be a defining part of his legacy, and I do wonder if that’s why he’s scrambling so hard to rewrite that history now," @jeremykonyndyk.bsky.social told me: www.theguardian.com/technology/2...

What will define Elon Musk’s legacy? Doge cuts to USAID Ebola programs

Experts say cuts have hindered the response to DRC’s Ebola outbreak and resulted in ‘significant numbers’ of deaths

theguardian.com

Probably a good time for a few general caveats for those watching the developing story of the #hantavirus outbreak linked to the cruise ship MV Hondius - especially the more anxious ones among you. (Long-time followers will know most of this by heart at this point): 🧪

MSI Reproductive Choices say UK aid cuts include a 23% funding reduction for the Women’s Integrated Sexual Health programme in West and Central Africa. They predict an additional 410k unintended pregnancies, 1k maternal deaths and 110k unsafe abortions as a result.

U.S. health officials insisted it was still on. African health leaders said it was cancelled. A hotly debated study on hepatitis B in Guinea-Bissau is indeed halted, as I reported last week. Here's my latest: www.theguardian.com/world/2026/j...

‘It’s the sovereignty of the country’: Guinea-Bissau says US vaccine study suspended

Despite US pushback, officials in west Africa say controversial hepatitis B study on pause amid ethics concerns

theguardian.com